Mayinglong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate
Mayinglong Pharmaceutical Group Co Ltd cash flow reinvestment rate. Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting CN¥13.73 Million (capex CN¥13.73 Million ) from operating cash flow of CN¥139.20 Million. Explore Mayinglong Pharmaceutical Group Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Cash flow reinvestment rate of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. Historical reinvestment intensity for Mayinglong Pharmaceutical Group Co Ltd across 22 annual periods. Explore Mayinglong Pharmaceutical Group Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Mayinglong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)
Mayinglong Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Mayinglong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Mayinglong Pharmaceutical Group Co Ltd (600993) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.44x | CN¥862.67 Million | CN¥600.44 Million | CN¥119.37 Million | ▲ +170.2% |
| 2024 | 0.53x | CN¥264.57 Million | CN¥497.61 Million | CN¥203.85 Million | ▼ -53.9% |
| 2023 | 1.15x | CN¥696.64 Million | CN¥604.07 Million | CN¥248.36 Million | ▼ -43.2% |
| 2022 | 2.03x | CN¥693.77 Million | CN¥341.85 Million | CN¥75.01 Million | ▲ +1091.8% |
| 2021 | 0.17x | CN¥101.69 Million | CN¥597.17 Million | CN¥65.10 Million | ▼ -86.8% |
| 2020 | 1.29x | CN¥365.76 Million | CN¥282.99 Million | CN¥45.41 Million | ▲ +746.3% |
| 2019 | 0.15x | CN¥75.07 Million | CN¥491.58 Million | CN¥46.36 Million | ▼ -28.2% |
| 2018 | 0.21x | CN¥65.52 Million | CN¥308.24 Million | CN¥24.96 Million | ▼ -43.1% |
| 2017 | 0.37x | CN¥133.13 Million | CN¥356.17 Million | CN¥41.91 Million | ▼ -74.6% |
| 2016 | 1.47x | CN¥352.23 Million | CN¥239.60 Million | CN¥65.24 Million | ▼ -5.7% |
| 2015 | 1.56x | CN¥285.18 Million | CN¥182.85 Million | CN¥123.93 Million | ▲ +63.0% |
| 2014 | 0.96x | CN¥106.87 Million | CN¥111.67 Million | CN¥106.87 Million | ▲ +48.6% |
| 2013 | 0.64x | CN¥83.68 Million | CN¥129.94 Million | CN¥83.68 Million | ▲ +232.8% |
| 2012 | 0.19x | CN¥32.75 Million | CN¥169.25 Million | CN¥32.75 Million | ▼ -67.4% |
| 2011 | 0.59x | CN¥44.69 Million | CN¥75.37 Million | CN¥44.69 Million | ▲ +266.9% |
| 2009 | 0.16x | CN¥34.93 Million | CN¥216.11 Million | CN¥34.93 Million | ▼ -49.5% |
| 2008 | 0.32x | CN¥32.84 Million | CN¥102.59 Million | CN¥32.84 Million | ▼ -91.6% |
| 2007 | 3.80x | CN¥24.65 Million | CN¥6.49 Million | CN¥24.65 Million | ▲ +1242.0% |
| 2006 | 0.28x | CN¥21.32 Million | CN¥75.27 Million | CN¥21.32 Million | ▼ -54.0% |
| 2005 | 0.62x | CN¥35.95 Million | CN¥58.43 Million | CN¥35.95 Million | ▲ +15.2% |
| 2004 | 0.53x | CN¥28.94 Million | CN¥54.19 Million | CN¥28.94 Million | ▲ +148.1% |
| 2003 | 0.22x | CN¥14.54 Million | CN¥67.52 Million | CN¥14.54 Million | — |